Inflammatory Myofibroblastic Tumour (IMT) of the Liver: A Report of Two Cases

Sevinc A. I., ÜNEK T., Astarcioglu H.

ACTA CHIRURGICA BELGICA, vol.110, no.1, pp.87-89, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 110 Issue: 1
  • Publication Date: 2010
  • Doi Number: 10.1080/00015458.2010.11680573
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.87-89
  • Keywords: Inflammatory myofibroblastic tumour, liver tumour, PSEUDOTUMOR
  • Dokuz Eylül University Affiliated: Yes


Inflammatory myofibroblastic tumour (IMT) is an uncommon mass lesion composed of myofibroblasts and mixed inflammatory infiltrate that rarely undergoes malignant transformation. Although IMT was originally reported in the lung, it is now recognised that it can occur in a variety of organs. Hepatic localisation of IMT is less frequent. Here we report two cases of IMT in the liver. They underwent hepatic resections with the diagnosis of FNH and Klatskin tumour. The pathological diagnosis of the tumour was IMT. We conclude that in the management of IMT in the liver, surgical excision is the primary choice, in order to obtain a definitive diagnosis as well as to relieve symptoms, and strict follow-up after Surgery is required for the timely detection of recurrence.